Skip to main content

Research Repository

Advanced Search

MDSCs drive the process of endometriosis by enhancing angiogenesis and are a new potential therapeutic target

Zhang, Tao; Zhou, Juhua; Man, Gene Chi Wai; Leung, Kam Tong; Liang, Bo; Xiao, Bo; Ma, Xinting; Huang, Shaoyan; Huang, Huaxiang; Hegde, Venkatesh L.; Zhong, Yin; Li, Yanmin; Kong, Grace Wing Shan; Yiu, Alice Ka Wah; Kwong, Joseph; Ng, Pak Cheung; Lessey, Bruce A.; Nagarkatti, Prakash S.; Nagarkatti, Mitzi; Wang, Chi Chiu

Authors

Tao Zhang

Juhua Zhou

Gene Chi Wai Man

Kam Tong Leung

Bo Liang

Bo Xiao

Xinting Ma

Shaoyan Huang

Huaxiang Huang

Venkatesh L. Hegde

Yin Zhong

Yanmin Li

Grace Wing Shan Kong

Alice Ka Wah Yiu

Pak Cheung Ng

Bruce A. Lessey

Prakash S. Nagarkatti

Mitzi Nagarkatti

Chi Chiu Wang



Abstract

Endometriosis affects women of reproductive age via unclear immunological mechanism(s). Myeloid-derived suppressor cells (MDSCs) are a heterogeneous group of myeloid cells with potent immunosuppressive and angiogenic properties. Here, we found MDSCs significantly increased in the peripheral blood of patients with endometriosis and in the peritoneal cavity of a mouse model of surgically induced endometriosis. Majority of MDSCs were granulocytic, produced ROS, and arginase, and suppressed T-cell proliferation. Depletion of MDSCs by antiGr-1 antibody dramatically suppressed development of endometrial lesions in mice. The chemokines CXCL1, 2, and 5 were expressed at sites of lesion while MDSCs expressed CXCR-2. These CXC-chemokines promoted MDSC migration toward endometriotic implants both in vitro and in vivo. Also, CXCR2-deficient mice show significantly decreased MDSC induction, endometrial lesions, and angiogenesis. Importantly, adoptive transfer of MDSCs into CXCR2-KO mice restored endometriotic growth and angiogenesis. Together, this study demonstrates that MDSCs play a role in the pathogenesis of endometriosis and identifies a novel CXC-chemokine and receptor for the recruitment of MDSCs, thereby providing a potential target for endometriosis treatment.

Citation

Zhang, T., Zhou, J., Man, G. C. W., Leung, K. T., Liang, B., Xiao, B., …Wang, C. C. (2018). MDSCs drive the process of endometriosis by enhancing angiogenesis and are a new potential therapeutic target. European Journal of Immunology, 48(6), 1059-1073. https://doi.org/10.1002/eji.201747417

Journal Article Type Article
Online Publication Date Mar 13, 2018
Publication Date 2018-06
Deposit Date Jun 23, 2023
Journal European Journal of Immunology
Print ISSN 0014-2980
Electronic ISSN 1521-4141
Publisher Wiley
Peer Reviewed Peer Reviewed
Volume 48
Issue 6
Pages 1059-1073
DOI https://doi.org/10.1002/eji.201747417
Keywords Immunology; Immunology and Allergy; Angiogenesis; CXCR2; Endometriosis; Immunosuppression; Myeloid-derived; suppressor cells